Methods And Compositions For Detecting A Drug Resistant Egfr Mutant

Patent No. EP1851339 (titled "Methods And Compositions For Detecting A Drug Resistant Egfr Mutant") was filed by Memorial Sloan Kettering Cancer Center on Feb 13, 2006. The application was issued on May 18, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KONIG SZYNKA TILMANN VON RENESSEFeb 20, 2017ROTH
ROCHEFeb 17, 2017BOSL
HOFFMANN EITLEFeb 15, 2017HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1851339

MEMORIAL SLOAN KETTERING CANCER CENTER
Application Number
EP06720702A
Filing Date
Feb 13, 2006
Status
Revoked
Apr 22, 2022
Publication Date
May 18, 2016